Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0305855 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Amarendra Mahapatra und 10 weiteren Autor:innen. Beteiligte Einrichtung: ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Quality of Life, Dietary Supplements, Antitubercular Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tata Trusts.
Abstract (Originalsprache)
Background
By encouraging treatment adherence and lowering mortality, dietary supplements can serve as adjuvant therapy for the success of medical interventions. We determined the effect of locally accessible food supplements on treatment outcomes, and health-related quality of life in patients with pulmonary tuberculosis initiating anti-tuberculosis treatment (ATT) in Odisha, India.
Method
Between September 2017 and December 2018, implementation research in patients with newly diagnosed sputum smear-positive pulmonary tuberculosis initiating ATT in five districts of the tribal belt of Odisha, offered food supplements along with ATT in a phased manner. Clinical symptoms, anthropometry, sputum for M. tuberculosis (M. tb), health-related quality of life and return to normal function were assessed periodically, and favourable treatment outcome (cure or treatment completed) was measured at the end of treatment. The effect of the food supplement on unfavorable outcomes (treatment failure, death, or lost-to-follow-up) was modelled using mixed-effects Poisson regression to determine the risk factors.
Results
Among the 761 participants enrolled, 614 participants received the food supplement and 147 did not receive the food supplement. Among the 614 participants in the supplement group, 537 (87%) had a favorable outcome and among the 147 participants in the no-supplement group, 113 (77%) had a favorable outcome (p = 0.0017). Higher age (>55 years) [aRR = 2.1(95% CI: 1.1–3.8)], male gender [aRR = 1.7(95% CI: 1.2–2.9)], and smear grading ≥2+ [aRR = 1.5 (95% CI: 1.1–2.2)] were associated with unfavorable treatment outcomes. Nutritional status, quality of life and lung health showed significant improvement from baseline in the supplement group.
Conclusion
Improvement in the nutritional status of the patient can be considered a predictor of treatment success rates. Early food supplementation has a positive impact on the nutritional status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
- ICMR-National Institute for Research in Tuberculosis, Chennai, India.
- Tata Trusts, Mumbai, India.
- Indian Council of Medical Research, New Delhi, India.
ORCID-Profile: Amarendra Mahapatra, Chandrasekaran Padmapriyadarsini
Förderung
- Tata Trusts
Zitieren
APA
Mahapatra, A., Thiruvengadam, K., Nair, D., Padmapriyadarsini, C., Thomas, B., Pati, S., Bulliyya, G., Das, D., Chowdhury, J., Bang, A., & Swaminathan, S. (2024). Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach. PLOS ONE. https://doi.org/10.1371/journal.pone.0305855
Vancouver
Mahapatra A, Thiruvengadam K, Nair D, Padmapriyadarsini C, Thomas B, Pati S, et al. Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach. PLOS ONE. 2024. doi:10.1371/journal.pone.0305855
BibTeX
@article{Mahapatra2024,
author = {Mahapatra, Amarendra and Thiruvengadam, Kannan and Nair, Dina and Padmapriyadarsini, Chandrasekaran and Thomas, Beena and Pati, Sanghamitra and Bulliyya, Gandham and Das, Dasarathi and Chowdhury, Jayeeta and Bang, Anand and Swaminathan, Soumya},
title = {Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0305855}
}
EUVIMED